Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kegel

Showing results (431-440 of 513) with videos related to

Pageof 52
Sort By:
Journal of the American Society of Nephrology : JASN|March 20, 2015
Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated VasculitisAnna Bertram, Svjetlana Lovric, Alissa Engel, et al.
Psychiatry Research|November 26, 2016
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidityMagdalena E Kegel, Viktoria Johansson, Lennart Wetterberg, et al.
Canadian Journal of Gastroenterology & Hepatology|July 6, 2018
Independent Heath Facility Meets Cancer Care Ontario and Canadian Association of Gastroenterology Guidelines for Endoscopic Procedure Wait Times While Meeting Quality Indicators: A Retrospective ReviewFraser Kegel, Niv Sne, Timothy Rice, et al.
The Journal of Surgical Research|October 28, 2008
Substance P enhances wound closure in nitric oxide synthase knockout micePornprom Muangman, Richard N Tamura, Lara A Muffley, et al.
Journal of Medicinal Chemistry|March 19, 2008
9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replicationHendrik Stukenbrock, Rainer Mussmann, Marcus Geese, et al.
Neurobiology of Disease|August 25, 2009
Disruption of Rab11 activity in a knock-in mouse model of Huntington's diseaseXueyi Li, Ellen Sapp, Kathryn Chase, et al.
Journal of Huntington'S Disease|September 24, 2015
Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic AcidPetr Vodicka, Shunyan Mo, Adelaide Tousley, et al.
Soft Matter|February 22, 2023
Is there a difference between surfactant-stabilised and Pickering emulsions?Riande I Dekker, Santiago F Velandia, Heleen V M Kibbelaar, et al.
Journal of Cancer Research and Clinical Oncology|October 20, 2012
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approvalDeniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, et al.
Leukemia & Lymphoma|June 18, 2014
Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009Christian Schmidt, Guenter Fingerle-Rowson, Angelika Boehme, et al.
Pageof 52

Showing results (431-440 of 513) with videos related to

Sort By:
Pageof 52
Journal of the American Society of Nephrology : JASN|March 20, 2015
Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated VasculitisAnna Bertram, Svjetlana Lovric, Alissa Engel, et al.
Psychiatry Research|November 26, 2016
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidityMagdalena E Kegel, Viktoria Johansson, Lennart Wetterberg, et al.
Canadian Journal of Gastroenterology & Hepatology|July 6, 2018
Independent Heath Facility Meets Cancer Care Ontario and Canadian Association of Gastroenterology Guidelines for Endoscopic Procedure Wait Times While Meeting Quality Indicators: A Retrospective ReviewFraser Kegel, Niv Sne, Timothy Rice, et al.
The Journal of Surgical Research|October 28, 2008
Substance P enhances wound closure in nitric oxide synthase knockout micePornprom Muangman, Richard N Tamura, Lara A Muffley, et al.
Journal of Medicinal Chemistry|March 19, 2008
9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replicationHendrik Stukenbrock, Rainer Mussmann, Marcus Geese, et al.
Neurobiology of Disease|August 25, 2009
Disruption of Rab11 activity in a knock-in mouse model of Huntington's diseaseXueyi Li, Ellen Sapp, Kathryn Chase, et al.
Journal of Huntington'S Disease|September 24, 2015
Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic AcidPetr Vodicka, Shunyan Mo, Adelaide Tousley, et al.
Soft Matter|February 22, 2023
Is there a difference between surfactant-stabilised and Pickering emulsions?Riande I Dekker, Santiago F Velandia, Heleen V M Kibbelaar, et al.
Journal of Cancer Research and Clinical Oncology|October 20, 2012
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approvalDeniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, et al.
Leukemia & Lymphoma|June 18, 2014
Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009Christian Schmidt, Guenter Fingerle-Rowson, Angelika Boehme, et al.
Pageof 52